1st Quarter - Termination
PARRY, ROMANI, DECONCINI & SYMMS for POZEN, INC.
Client
Income
$24,000
Expenses
—
Terminated
Feb 28, 2015
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support H.R. 2985, The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Pharmacy PHA
Support H.R. 2985, The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.